Rh blood group D antigen (RhD)

The Rh blood group D antigen—commonly called RhD—is a transmembrane protein found on human erythrocytes. It is encoded by the *RHD* gene located on chromosome 1. The presence or absence of this protein defines whether an individual is classified as "Rh positive" or "Rh negative." The protein spans the membrane 12 times and forms part of a larger macromolecular complex with other proteins such as RhCE and RhAG. While its precise physiological function remains incompletely understood, it may be involved in ammonia transport across cell membranes. Clinically, the most important aspect of this molecule is its role as an alloantigen that can provoke strong immune responses during pregnancy or after incompatible transfusions. Anti-D antibodies are highly immunogenic IgG molecules that can cross the placenta and cause hemolysis in fetuses carrying paternal *RHD* alleles when their mothers are *RHD*-negative. This underlies both hemolytic disease of newborns and delayed hemolytic transfusion reactions. The term “Erythrocyte D-antigen” refers specifically to this surface marker but should not be considered a classical drug target such as receptors or enzymes; rather it serves primarily for diagnostic purposes in transfusion medicine.[2][3][6] **Note:** There is something incorrect about considering “Erythrocyte D-antigen” as a typical therapeutic target—it functions mainly as an alloantigen/blood group marker rather than being targeted by drugs for modulation of biological pathways.[2][3]

Other names

D antigenRhesus D antigenCD240DRh polypeptide 1 (RhPI)RH30RHDRh blood group D antigen[7]

Not applicable; anti-D immunoglobulin binds to the D antigen on fetal red cells to prevent maternal immune sensitization but does not modulate a signaling pathway or enzymatic activity